 Aaron Issaian
Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 7 | 2025 | 698 | 1.210 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 1 | 2021 | 22 | 0.720 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 3 | 2022 | 344 | 0.580 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 465 | 0.490 |
Why?
| | Fluid Therapy | 2 | 2026 | 143 | 0.440 |
Why?
| | Hemolysis | 3 | 2025 | 206 | 0.410 |
Why?
| | Resuscitation | 2 | 2026 | 295 | 0.390 |
Why?
| | Protein Domains | 4 | 2022 | 305 | 0.380 |
Why?
| | Blood Preservation | 3 | 2025 | 307 | 0.330 |
Why?
| | Sepsis | 2 | 2026 | 627 | 0.300 |
Why?
| | Glucosephosphate Dehydrogenase | 2 | 2025 | 63 | 0.280 |
Why?
| | Chondroitin Sulfates | 1 | 2026 | 35 | 0.240 |
Why?
| | Glycocalyx | 1 | 2025 | 29 | 0.230 |
Why?
| | Receptor, Adenosine A2B | 1 | 2025 | 65 | 0.230 |
Why?
| | Caffeine | 1 | 2025 | 72 | 0.230 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.220 |
Why?
| | Vasoconstrictor Agents | 1 | 2025 | 136 | 0.220 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 1 | 2024 | 30 | 0.210 |
Why?
| | Models, Molecular | 5 | 2021 | 1602 | 0.210 |
Why?
| | Blood Donors | 2 | 2025 | 115 | 0.210 |
Why?
| | Pteridines | 1 | 2023 | 21 | 0.200 |
Why?
| | Furin | 1 | 2022 | 14 | 0.200 |
Why?
| | Oxidation-Reduction | 3 | 2021 | 1080 | 0.190 |
Why?
| | Aldehydes | 1 | 2023 | 146 | 0.190 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 106 | 0.180 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 53 | 0.180 |
Why?
| | Blood Banks | 1 | 2021 | 47 | 0.180 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 65 | 0.160 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 123 | 0.160 |
Why?
| | Membrane Lipids | 1 | 2020 | 82 | 0.160 |
Why?
| | Factor XIIIa | 1 | 2019 | 6 | 0.150 |
Why?
| | Glycolysis | 4 | 2025 | 325 | 0.150 |
Why?
| | Prescription Drugs | 1 | 2021 | 112 | 0.150 |
Why?
| | RNA-Binding Proteins | 1 | 2023 | 448 | 0.150 |
Why?
| | Peptide Mapping | 1 | 2019 | 65 | 0.150 |
Why?
| | Solutions | 1 | 2019 | 168 | 0.150 |
Why?
| | Endothelium, Vascular | 1 | 2025 | 943 | 0.150 |
Why?
| | Introns | 1 | 2019 | 253 | 0.140 |
Why?
| | Fibrin | 1 | 2019 | 90 | 0.140 |
Why?
| | Exons | 1 | 2019 | 352 | 0.140 |
Why?
| | Energy Metabolism | 2 | 2021 | 926 | 0.140 |
Why?
| | RNA Splicing | 1 | 2019 | 271 | 0.140 |
Why?
| | Streptococcus pneumoniae | 1 | 2019 | 167 | 0.140 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 7 | 0.130 |
Why?
| | RNA | 1 | 2023 | 927 | 0.130 |
Why?
| | Histidine Kinase | 1 | 2016 | 33 | 0.130 |
Why?
| | Autism Spectrum Disorder | 1 | 2022 | 418 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 374 | 0.120 |
Why?
| | Metals | 1 | 2016 | 140 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 370 | 0.120 |
Why?
| | Glucose | 2 | 2021 | 1027 | 0.110 |
Why?
| | Saccharomyces cerevisiae | 1 | 2019 | 556 | 0.110 |
Why?
| | Guanylate Cyclase | 1 | 2013 | 38 | 0.100 |
Why?
| | Oxidative Stress | 2 | 2021 | 1327 | 0.100 |
Why?
| | Indazoles | 1 | 2013 | 77 | 0.100 |
Why?
| | Peptides | 1 | 2019 | 971 | 0.100 |
Why?
| | Mice | 4 | 2025 | 17969 | 0.100 |
Why?
| | Bacterial Proteins | 1 | 2019 | 913 | 0.100 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 207 | 0.090 |
Why?
| | Signal Transduction | 1 | 2025 | 5116 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1655 | 0.090 |
Why?
| | Humans | 14 | 2026 | 141284 | 0.090 |
Why?
| | Erythrocyte Transfusion | 2 | 2025 | 208 | 0.090 |
Why?
| | Animals | 6 | 2025 | 37328 | 0.080 |
Why?
| | Mutation | 1 | 2021 | 4006 | 0.080 |
Why?
| | Metabolomics | 3 | 2021 | 702 | 0.080 |
Why?
| | Proteome | 2 | 2023 | 483 | 0.070 |
Why?
| | Proteins | 2 | 2022 | 1007 | 0.060 |
Why?
| | Syndecan-1 | 1 | 2025 | 41 | 0.060 |
Why?
| | Protein Conformation | 2 | 2021 | 939 | 0.060 |
Why?
| | Antimalarials | 1 | 2024 | 33 | 0.050 |
Why?
| | Hyaluronic Acid | 1 | 2026 | 227 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2026 | 775 | 0.040 |
Why?
| | Glutathione Disulfide | 1 | 2021 | 33 | 0.040 |
Why?
| | Ranitidine | 1 | 2021 | 14 | 0.040 |
Why?
| | NADP | 1 | 2021 | 51 | 0.040 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2021 | 46 | 0.040 |
Why?
| | Immune Evasion | 1 | 2021 | 63 | 0.040 |
Why?
| | Male | 5 | 2026 | 70140 | 0.040 |
Why?
| | Genome | 1 | 2022 | 303 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2021 | 212 | 0.040 |
Why?
| | Aged | 3 | 2026 | 24836 | 0.040 |
Why?
| | Genome, Human | 1 | 2022 | 420 | 0.040 |
Why?
| | Protein Structure, Quaternary | 1 | 2019 | 120 | 0.040 |
Why?
| | Spliceosomes | 1 | 2019 | 50 | 0.040 |
Why?
| | High-Throughput Screening Assays | 1 | 2021 | 158 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1059 | 0.040 |
Why?
| | Bacterial Adhesion | 1 | 2019 | 104 | 0.040 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2019 | 92 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 738 | 0.040 |
Why?
| | Hemoglobins | 1 | 2021 | 361 | 0.040 |
Why?
| | Cryoelectron Microscopy | 1 | 2019 | 193 | 0.040 |
Why?
| | Fibrinogen | 1 | 2019 | 179 | 0.030 |
Why?
| | Middle Aged | 3 | 2026 | 34658 | 0.030 |
Why?
| | Binding Sites | 1 | 2021 | 1311 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 277 | 0.030 |
Why?
| | Ligands | 1 | 2019 | 665 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2021 | 503 | 0.030 |
Why?
| | Metabolome | 1 | 2020 | 366 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 589 | 0.030 |
Why?
| | Lysine | 1 | 2019 | 292 | 0.030 |
Why?
| | Female | 4 | 2026 | 75814 | 0.030 |
Why?
| | Circular Dichroism | 1 | 2016 | 148 | 0.030 |
Why?
| | Dimerization | 1 | 2016 | 196 | 0.030 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 333 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2016 | 165 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2019 | 734 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2019 | 403 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 555 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2019 | 2146 | 0.030 |
Why?
| | Thrombosis | 1 | 2019 | 399 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3172 | 0.030 |
Why?
| | Biomarkers | 1 | 2026 | 4180 | 0.030 |
Why?
| | Manduca | 1 | 2013 | 3 | 0.030 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2013 | 15 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1144 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4414 | 0.030 |
Why?
| | Allosteric Regulation | 1 | 2013 | 88 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 3042 | 0.030 |
Why?
| | Carbon Monoxide | 1 | 2013 | 83 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2013 | 88 | 0.030 |
Why?
| | Heme | 1 | 2013 | 75 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2016 | 630 | 0.020 |
Why?
| | Models, Biological | 1 | 2021 | 1810 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2016 | 565 | 0.020 |
Why?
| | Protein Subunits | 1 | 2013 | 228 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2013 | 858 | 0.020 |
Why?
| | Cattle | 1 | 2013 | 982 | 0.020 |
Why?
| | Adult | 2 | 2025 | 39319 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 5866 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2013 | 894 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 2233 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 13727 | 0.010 |
Why?
| | Adolescent | 1 | 2021 | 22116 | 0.010 |
Why?
|
|
Issaian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|